Kingdon Capital Management, L.L.C. Scynexis Inc Transaction History
Kingdon Capital Management, L.L.C.
- $613 Million
- Q4 2024
A detailed history of Kingdon Capital Management, L.L.C. transactions in Scynexis Inc stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 2,237,048 shares of SCYX stock, worth $2.26 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
2,237,048
Previous 2,237,048
-0.0%
Holding current value
$2.26 Million
Previous $3.33 Million
22.83%
% of portfolio
0.42%
Previous 0.4%
Shares
9 transactions
Others Institutions Holding SCYX
# of Institutions
53Shares Held
12.7MCall Options Held
9KPut Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA2.9MShares$2.92 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$1.68 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.23MShares$1.24 Million0.16% of portfolio
-
Amh Equity LTD626KShares$632,3120.79% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$561,1100.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $33M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...